Adaptimmune Therapeutics
ADAP.nasdaq
Adaptimmune Therapeutics (NASDAQ:ADAP.NASDAQ) is an asset listed on the NASDAQ, and part of the Health Care sector. Grafa’s asset page shows Adaptimmune Therapeutics ’s share price, chart, trading volume, earnings per share, dividends per share and P/E ratio. You can also see how many (NASDAQ:ADAP.NASDAQ) shares are being shorted as well as market sensitive announcements about Adaptimmune Therapeutics .
ADAP share price
Last price | $0.60 | |
|---|---|---|
Change | 0.007 (1.23%) | |
Volume | 2M | |
Volume traded/total % | 0.928% | |
Volume avg (4w) | 2M | |
Open | $0.60 | |
Day range | $0.584 - $0.62 | |
Previous Close | $0.593 | |
Last Trade | 19 Dec, 9:00 pm UTC |
1 Week | 3.43% | |
|---|---|---|
1 Month | -11.085% | |
YTD | -19.571% | |
1 Year | 26.93% |
Shares Issued | 256M | |
|---|---|---|
Earnings Per Share (EPS) | $-0.17 | |
Dividends Per Share (DPS) | $0.00 | |
P/E Ratio | 0.00 |
Market Cap | $155.07M | |
|---|---|---|
Market Rank | 2274 | |
Industry Rank | 306 |
Set ADAP.NASDAQ share price alert
Price alerts
On Adaptimmune Therapeutics ADAP.NASDAQ dividend history
Check out Adaptimmune Therapeutics 's dividend track record
Oh no, Adaptimmune Therapeutics has no dividend data to show
Key Dividend Data
-
Dividend Per Share (TTM)
-
Dividend Yield
-
Payout Ratio
-
Dividend Reinvestment Plan
| Ex-date | Amount | Franking | Type | Payable-date |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
ADAP NASDAQ announcements
This is all recent announcements from ADAP
19/12/2024 12:40 PM
8-k - adaptimmune therapeutics plc (0001621227) (filer)
05/12/2024 10:17 PM
schedule 13g/a - adaptimmune therapeutics plc (0001621227) (subject)
13/11/2024 02:10 PM
8-k - adaptimmune therapeutics plc (0001621227) (filer)
13/11/2024 02:04 PM
sc 13g/a - adaptimmune therapeutics plc (0001621227) (subject)
01/11/2024 09:00 PM
8-k - adaptimmune therapeutics plc (0001621227) (filer)
23/09/2024 08:15 PM
8-k - adaptimmune therapeutics plc (0001621227) (filer)
ADAP NASDAQ short positions
Chart shows percentage of shares on issue being shorted
Sentiment
31 Oct 2024
2.092%
of ADAP shares are currently being shorted
This is lower than the Health Care sector average
Adaptimmune Therapeutics sentiment:
This Weekpositive
This Quarterpositive
This Yearpositive